Fingerprint
Dive into the research topics of 'Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-hodgkin's lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-hodgkin's lymphoma
Leo I. Gordon*, Thomas E. Witzig, Greg A. Wiseman, Ian W. Flinn, Stewart S. Spies, Daniel H. Silverman, Christos Emmanuolides, Larry Cripe, Mansoor Saleh, Myron S. Czuczman, Teresa Olejnik, Christine A. White, Antonio J. Grillo-López
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
67
Scopus
citations